Costs and consequences: Hepatitis C seroprevalence in the military and its impact on potential screening strategies.
Brett-Major DM, Frick KD, Malia JA, Hakre S, Okulicz JF, Beckett CG, Jagodinski LL, Forgione MA, Gould PL, Harrison SA, Murray CK, Rentas FJ, Armstrong AW, Hayat AM, Pacha LA, Dawson P, Eick-Cost AA, Maktabi HH, Michael NL, Cersovsky SB, Peel SA, Scott PT.
Brett-Major DM, et al. Among authors: gould pl.
Hepatology. 2016 Feb;63(2):398-407. doi: 10.1002/hep.28303. Epub 2015 Dec 9.
Hepatology. 2016.
PMID: 26481723